Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02246413 · ClinicalTrials.gov registry record · NA
Research Aimed at Improving Both Mood and Weight
A NA study, sponsored by Palo Alto Medical Foundation.
- Completed
- Registry status
- NA
- Development phase
- 409
- Enrollment target
NCT02246413: Completed NA study, sponsored by Palo Alto Medical Foundation.
NCT02246413 is a NA study that has completed, run by Palo Alto Medical Foundation. The registered enrollment target is 409 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02246413, a NA study, has completed, sponsored by Palo Alto Medical Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 409 participants
- Enrollment target
Study Summary
The RAINBOW study is an NIH R01-funded randomized controlled trial to evaluate the clinical and cost effectiveness and implementation potential of a primary care integrated multicondition intervention program to help improve mood and weight for obese adults with clinically significant depressive symptoms. The ENGAGE study is a mechanistic investigation added to the main trial with funding through the NIH common fund for the Science of Behavior Change roadmap initiative. Beginning Jan 11, 2016, at least 100 of newly enrolled trial participants will be consented to undergo additional assays evaluating neurobiological mechanisms of self-regulation.
Primary Outcome
Integrated intervention treatment response
Interventions
- BEHAVIORAL RAINBOW Intervention Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 409 participants |
| Start Date | 2014-09-30 |
| Est. Completion | 2018-12-21 |
| Phase | NA |
What the finished NCT02246413 record still lists
NCT02246413 is an interventional study that assigns participants to a tested intervention. The registered 409 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 1 intervention - of which RAINBOW Intervention Program is the first listed.
NCT02246413 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02246413 about?
NCT02246413 is a clinical study titled "Research Aimed at Improving Both Mood and Weight". The RAINBOW study is an NIH R01-funded randomized controlled trial to evaluate the clinical and cost effectiveness and implementation potential of a primary care integrated multicondition intervention program to help improve mood and weight for obese adults with clinically significant depressive sym...
What is the current status of trial NCT02246413?
This trial is currently completed. It is a NA study. The enrollment target is 409 participants. The study started on 2014-09-30. Estimated completion is 2018-12-21.
What interventions are being tested in trial NCT02246413?
The interventions under investigation include: RAINBOW Intervention Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02246413?
This trial is sponsored by Palo Alto Medical Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02246413's enrollment target sits among peer trials
409 243rd of 2000 higher than 1,758 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06717334 · 409 participants
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
- NCT05730036 · 410 participants · Phase 3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI